These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Delaware
|
|
81-5266334
|
|
(State or other jurisdiction of incorporation or
organization)
|
|
(I.R.S. Employer Identification No.)
|
|
Large
accelerated filer
☐
|
Accelerated
filer
☐
|
|
Non-accelerated
filer
☒
|
Smaller
reporting company
☒
|
|
|
Emerging
growth company
☐
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common
Stock, $0.0001 par value per share
|
REKR
|
The
Nasdaq Stock Market
|
|
PART I
- FINANCIAL INFORMATION
|
4
|
|
|
ITEM
1. FINANCIAL STATEMENTS
|
4
|
|
|
UNAUDITED
CONDENSED CONSOLIDATED BALANCE SHEETS
|
4
|
|
|
UNAUDITED CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
5
|
|
|
UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(DEFICIT)
|
6
|
|
|
UNAUDITED CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
7
|
|
|
NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS
|
8
|
|
|
ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
|
31
|
|
|
ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
|
45
|
|
|
ITEM
4. CONTROLS AND PROCEDURES
|
45
|
|
|
|
|
|
|
PART
II - OTHER INFORMATION
|
46
|
|
|
ITEM
1. LEGAL PROCEEDINGS
|
46
|
|
|
ITEM
1A. RISK FACTORS
|
47
|
|
|
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
PROCEEDS
|
47
|
|
|
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
|
47
|
|
|
ITEM
4. MINE SAFETY DISCLOSURES
|
47
|
|
|
ITEM
5. OTHER INFORMATION
|
47
|
|
|
ITEM
6. EXHIBITS
|
48
|
|
|
|
|
|
|
SIGNATURES
|
49
|
|
|
|
March
31,
2021
|
December
31,
2020
|
|
ASSETS
|
|
|
|
Current
Assets
|
|
|
|
Cash and cash
equivalents
|
$
62,845
|
$
20,595
|
|
Restricted cash and
cash equivalents
|
1,005
|
412
|
|
Short-term
investments
|
23,996
|
-
|
|
Accounts receivable,
net
|
2,474
|
1,038
|
|
Inventory
|
1,101
|
1,264
|
|
Note receivable,
current portion
|
340
|
340
|
|
Other current assets,
net
|
626
|
469
|
|
Current assets of
discontinued operations
|
1
|
2
|
|
Total
current assets
|
92,388
|
24,120
|
|
Long-term
Assets
|
|
|
|
Property and equipment,
net
|
1,337
|
1,047
|
|
Right-of-use lease
assets, net
|
352
|
426
|
|
Goodwill
|
6,336
|
6,336
|
|
Intangible assets,
net
|
6,633
|
7,038
|
|
Investments in
unconsolidated companies
|
74
|
75
|
|
Note receivable,
long-term
|
1,275
|
1,360
|
|
Total
long-term assets
|
16,007
|
16,282
|
|
Total
assets
|
$
108,395
|
$
40,402
|
|
LIABILITIES
AND SHAREHOLDERS' EQUITY
|
|
|
|
Current
Liabilities
|
|
|
|
Accounts payable and
accrued expenses
|
$
4,712
|
$
3,898
|
|
Notes payable, current
portion
|
985
|
-
|
|
Loan payable, current
portion
|
625
|
517
|
|
Lease liability,
short-term
|
199
|
253
|
|
Contract
liabilities
|
1,497
|
1,126
|
|
Current liabilities of
discontinued operations
|
128
|
124
|
|
Total
current liabilities
|
8,146
|
5,918
|
|
Long-term
Liabilities
|
|
|
|
Notes payable,
long-term
|
-
|
980
|
|
Loan payable,
long-term
|
350
|
469
|
|
Lease liability,
long-term
|
167
|
188
|
|
Contract liabilities,
long-term
|
910
|
958
|
|
Deferred tax liability,
long-term
|
27
|
24
|
|
Long term liabilities
of discontinued operations
|
-
|
5
|
|
Total
long-term liabilities
|
1,454
|
2,624
|
|
Total
liabilities
|
9,600
|
8,542
|
|
Series A Cumulative
Convertible Redeemable Preferred stock, $0.0001 par value;
authorized: 505,000 shares authorized at March 31, 2021 and
December 31, 2020; issued and outstanding: 0 and 502,327 shares
issued and outstanding at March 31, 2021 and December 31,
2020
|
-
|
6,669
|
|
Commitments
and Contingencies
|
|
|
|
Stockholders'
Equity
|
|
|
|
Common stock, $0.0001 par value;
authorized; 100,000,000 shares; issued: 40,972,238 shares at March
31, 2021 and 33,013,271 at December 31, 2020; outstanding:
40,952,877 shares at March 31, 2021 and 33,013,271 at December 31,
2020
|
4
|
3
|
|
Preferred stock,
$0.0001 par value, 2,000,000 authorized, 505,000 shares designated
as Series A and 240,861 shares designated as Series B as of March
31, 2021 and December 31, 2020, respectively
|
|
|
|
Series B Cumulative
Convertible Preferred stock, $0.0001 par value; authorized: 240,861
shares authorized at March 31, 2021 and December 31, 2020; issued
and outstanding: 0 and 240,861 shares issued and outstanding at
March 31, 2021 and December 31, 2020
|
-
|
-
|
|
Treasury stock, 19,361
and 0 shares as of March 31, 2021 and December 31, 2020,
respectively
|
(319
)
|
-
|
|
Additional paid-in
capital
|
147,615
|
68,238
|
|
Accumulated other
comprehensive income
|
2
|
-
|
|
Accumulated
deficit
|
(48,507
)
|
(43,050
)
|
|
Total
stockholders’ equity
|
98,795
|
25,191
|
|
Total
liabilities and stockholders’ equity
|
$
108,395
|
$
40,402
|
|
|
Three
months ended March 31,
|
|
|
|
2021
|
2020
|
|
Revenue
|
$
4,216
|
$
1,595
|
|
Cost
of revenue
|
1,962
|
494
|
|
Gross
profit
|
2,254
|
1,101
|
|
|
|
|
|
Operating
expenses:
|
|
|
|
General
and administrative expenses
|
5,403
|
2,791
|
|
Selling
and marketing expenses
|
937
|
371
|
|
Research
and development expenses
|
1,222
|
543
|
|
Operating
expenses
|
7,562
|
3,705
|
|
|
|
|
|
Loss
from operations
|
(5,308
)
|
(2,604
)
|
|
Other
income (expense):
|
|
|
|
Interest
expense
|
(32
)
|
(1,163
)
|
|
Other
income
|
16
|
-
|
|
Total
other expense
|
(16
)
|
(1,163
)
|
|
Loss
before income taxes
|
(5,324
)
|
(3,767
)
|
|
Income
tax provision
|
(3
)
|
(7
)
|
|
Equity
in loss of investee
|
(76
)
|
-
|
|
Net
loss from continuing operations
|
(5,403
)
|
(3,774
)
|
|
Net
loss from discontinued operations
|
(3
)
|
(14
)
|
|
Net
loss
|
$
(5,406
)
|
$
(3,788
)
|
|
Comprehensive
loss:
|
|
|
|
Net
loss from continuing operations
|
(5,403
)
|
(3,774
)
|
|
Change
in unrealized gain on short-term investments
|
2
|
-
|
|
Total
comprehensive loss from continuing operations
|
(5,401
)
|
(3,774
)
|
|
Total
comprehensive loss
|
$
(5,404
)
|
$
(3,788
)
|
|
Loss
per common share from continuing operations - basic and
diluted
|
(0.15
)
|
(0.19
)
|
|
Loss
per common share discontinued operations - basic and
diluted
|
-
|
-
|
|
Loss
per common share - basic and diluted
|
$
(0.15
)
|
$
(0.19
)
|
|
|
|
|
|
Weighted
average shares outstanding
|
|
|
|
Basic
and diluted
|
35,944,355
|
21,929,768
|
|
|
Shares
of Common Stock
|
Common
Stock
|
Shares
of Treasury Stock
|
Treasury
Stock at Cost
|
Shares
of Series B Preferred Stock
|
Series B
Preferred Stock
|
Additional
Paid-In Capital
|
Accumulated
Other Comprehensive Income
|
Accumulated
Deficit
|
Total
Stockholders’ Equity (Deficit)
|
|
Balance as of December 31, 2019
|
21,595,653
|
$
2
|
-
|
$
-
|
240,861
|
$
-
|
$
19,371
|
$
-
|
$
(28,408
)
|
$
(9,035
)
|
|
Stock-based
compensation
|
-
|
-
|
-
|
-
|
-
|
-
|
171
|
-
|
-
|
171
|
|
Exercise of
cashless warrants in exchange for common stock
|
43,218
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Exercise of
warrants in exchange for common stock
|
555,000
|
-
|
-
|
-
|
-
|
-
|
411
|
-
|
-
|
411
|
|
Issuance of
common stock pursuant to at the market offering,
net
|
536,730
|
-
|
-
|
-
|
-
|
-
|
2,169
|
-
|
-
|
2,169
|
|
Exercise of
warrants related to series A preferred stock
|
36,862
|
-
|
-
|
-
|
-
|
-
|
38
|
-
|
-
|
38
|
|
Issuance upon
exercise of stock options
|
1,294
|
-
|
-
|
-
|
-
|
-
|
5
|
-
|
-
|
5
|
|
Preferred
stock dividends
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(115
)
|
(115
)
|
|
Accretion of
Series A preferred stock
|
-
|
-
|
-
|
-
|
-
|
-
|
(206
)
|
-
|
-
|
(206
)
|
|
Net
loss
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,788
)
|
(3,788
)
|
|
Balance as of March 31, 2020
|
22,768,757
|
$
2
|
-
|
$
-
|
240,861
|
$
-
|
$
21,959
|
$
-
|
$
(32,311
)
|
$
(10,350
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2020
|
33,013,271
|
$
3
|
-
|
$
-
|
240,861
|
$
-
|
$
68,238
|
$
-
|
$
(43,050
)
|
$
25,191
|
|
Stock-based
compensation
|
-
|
-
|
-
|
-
|
-
|
-
|
781
|
-
|
-
|
781
|
|
Exercise of
cashless warrants in exchange for common stock
|
47,612
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Exercise of
warrants in exchange for common stock
|
52,013
|
-
|
-
|
-
|
-
|
-
|
294
|
-
|
-
|
294
|
|
Exercise of
warrants related to series A preferred stock
|
95,864
|
-
|
-
|
-
|
-
|
-
|
99
|
-
|
-
|
99
|
|
Public
underwriting
|
6,126,939
|
1
|
-
|
-
|
-
|
-
|
70,124
|
-
|
-
|
70,125
|
|
Conversion of
series A preferred stock
|
899,174
|
-
|
-
|
-
|
-
|
-
|
7,775
|
-
|
-
|
7,775
|
|
Conversion of
series B preferred stock
|
517,611
|
-
|
-
|
-
|
(240,861
)
|
-
|
179
|
-
|
-
|
179
|
|
Issuance upon
exercise of stock options
|
65,402
|
-
|
-
|
-
|
-
|
-
|
226
|
-
|
-
|
226
|
|
Issuance upon
vesting of restricted stock units
|
134,991
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Shares
withheld upon vesting of restricted stock units
|
-
|
-
|
(19,361
)
|
(319
)
|
-
|
-
|
-
|
-
|
-
|
(319
)
|
|
Preferred
stock dividends
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(51
)
|
(51
)
|
|
Accretion of
Series A preferred stock
|
-
|
-
|
-
|
-
|
-
|
-
|
(101
)
|
-
|
-
|
(101
)
|
|
Change in
unrealized gain on short-term investments
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2
|
-
|
2
|
|
Net
loss
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(5,406
)
|
(5,406
)
|
|
Balance as of March 31, 2021
|
40,952,877
|
$
4
|
(19,361
)
|
$
(319
)
|
-
|
$
-
|
$
147,615
|
$
2
|
$
(48,507
)
|
$
98,795
|
|
|
Three
Months ended March 31,
|
|
|
|
2021
|
2020
|
|
Cash Flows from Operating Activities
|
|
|
|
Net
loss from continuing operations
|
$
(5,403
)
|
$
(3,774
)
|
|
Net
loss from discontinued operations
|
(3
)
|
(14
)
|
|
Net
loss
|
(5,406
)
|
(3,788
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|
|
|
Bad debt expense
|
24
|
-
|
|
Depreciation
|
131
|
78
|
|
Amortization of right-of-use lease asset
|
74
|
32
|
|
Provision for deferred taxes
|
3
|
7
|
|
Share-based compensation
|
781
|
171
|
|
Amortization of financing costs
|
5
|
330
|
|
Amortization of intangible assets
|
409
|
313
|
|
Loss due to change in value of equity
investments
|
76
|
-
|
|
Changes
in operating assets and liabilities:
|
|
|
|
Accounts
receivable
|
(1,460
)
|
39
|
|
Inventory
|
163
|
(186
)
|
|
Other
current assets
|
(157
)
|
(213
)
|
|
Accounts
payable and accrued expenses
|
1,947
|
747
|
|
Contract
liabilities
|
323
|
(38
)
|
|
Lease
liability
|
(75
)
|
50
|
|
Net
cash used in operating activities - continuing
operations
|
(3,159
)
|
(2,444
)
|
|
Net
cash (used in) provided by operating activities - discontinued
operations
|
(4
)
|
452
|
|
Net
cash used in operating activities
|
(3,163
)
|
(1,992
)
|
|
Cash Flows from Investing Activities
|
|
|
|
Short-term
investment activity, net
|
(23,994
)
|
-
|
|
Capital
expenditures
|
(425
)
|
(178
)
|
|
Investment
in unconsolidated company
|
(75
)
|
-
|
|
Payment
of notes payable
|
(11
)
|
-
|
|
Proceeds
from notes receivable
|
85
|
-
|
|
Net
cash used in investing activities - continuing
operations
|
(24,420
)
|
(178
)
|
|
Cash Flows from Financing Activities
|
|
|
|
Proceeds
from public offering
|
70,125
|
-
|
|
Net
proceeds from exercise of options
|
226
|
5
|
|
Net
proceeds from exercise of warrants
|
294
|
411
|
|
Net
proceeds from exercise of warrants associated with the Series A
Preferred Stock
|
99
|
38
|
|
Net
proceeds from at-the-market agreement
|
-
|
2,169
|
|
Repurchases
of common stock
|
(319
)
|
-
|
|
Payment
of debt modification costs
|
-
|
(100
)
|
|
Net
cash provided by financing activities - continuing
operations
|
70,425
|
2,523
|
|
Net
used in financing activities - discontinued operations
|
-
|
(556
)
|
|
Net
cash provided by financing activities
|
70,425
|
1,967
|
|
Net
increase (decrease) in cash, cash equivalents and restricted cash
and cash equivalents - continuing operations
|
42,846
|
(99
)
|
|
Net
decrease in cash, cash equivalents and restricted cash and cash
equivalents - discontinued operations
|
(4
)
|
(104
)
|
|
Net
increase (decrease) in cash, cash equivalents and restricted cash
and cash equivalents
|
42,842
|
(203
)
|
|
Cash,
cash equivalents and restricted cash and cash equivalents at
beginning of period
|
21,009
|
1,866
|
|
Cash,
cash equivalents and restricted cash and cash equivalents at end of
period
|
$
63,851
|
$
1,663
|
|
|
|
|
|
Reconciliation of cash, cash equivalents and restricted
cash:
|
|
|
|
Cash
and cash equivalents at end of period - continuing
operations
|
$
62,845
|
$
1,087
|
|
Restricted
cash and cash equivalents at end of period - continuing
operations
|
1,005
|
415
|
|
Cash
and cash equivalents at end of period - discontinued
operations
|
1
|
161
|
|
Cash,
cash equivalents and restricted cash and cash equivalents at end of
period
|
$
63,851
|
$
1,663
|
|
|
Three
Months ended March 31,
|
|
|
|
2021
|
2020
|
|
Revenue
|
|
|
|
Licensing
and subscription revenue
|
$
3,301
|
$
850
|
|
Automated
traffic safety solutions
|
915
|
745
|
|
Total
revenue
|
$
4,216
|
$
1,595
|
|
|
Three
Months ended March 31,
|
|
|
|
2021
|
2020
|
|
Revenue
|
|
|
|
Commercial
customers
|
$
3,105
|
$
791
|
|
Government
customers
|
1,111
|
804
|
|
Total
revenue
|
$
4,216
|
$
1,595
|
|
2021
|
$
1,290
|
|
2022
|
553
|
|
2023
|
342
|
|
2024
|
182
|
|
2025
|
39
|
|
Thereafter
|
1
|
|
Total
|
$
2,407
|
|
|
March
31, 2021
|
December
31, 2020
|
|
|
Firestorm
|
Firestorm
|
|
ASSETS
|
|
|
|
Cash
and cash equivalents
|
$
1
|
$
2
|
|
Current
assets of discontinued operations
|
1
|
2
|
|
Total
assets of discontinued operations
|
$
1
|
$
2
|
|
LIABILITIES
|
|
|
|
Accounts
payable and accrued expenses
|
$
30
|
$
31
|
|
Lease
liability, short term
|
98
|
93
|
|
Current
liabilities of discontinued operations
|
128
|
124
|
|
Lease
liability, long term
|
-
|
5
|
|
Long-term
liabilities of discontinued operations
|
-
|
5
|
|
Total
liabilities of discontinued operations
|
$
128
|
$
129
|
|
|
Three
Months ended March 31,
|
||||
|
|
2021
|
2020
|
|||
|
|
Firestorm
|
Global
|
AOC Key
Solutions
|
Firestorm
|
Total
|
|
Revenue
|
$
-
|
$
6,305
|
$
3,392
|
$
-
|
$
9,697
|
|
Cost
of revenue
|
-
|
5,476
|
1,866
|
-
|
7,342
|
|
Gross
profit
|
-
|
829
|
1,526
|
-
|
2,355
|
|
Operating
expenses:
|
|
|
|
|
|
|
General
and administrative expenses
|
3
|
762
|
1,284
|
(4
)
|
2,042
|
|
Selling
and marketing expenses
|
-
|
39
|
131
|
-
|
170
|
|
Operating
expenses
|
3
|
801
|
1,415
|
(4
)
|
2,212
|
|
Income
loss income from operations
|
(3
)
|
28
|
111
|
4
|
143
|
|
Other
(income) expense:
|
|
|
|
|
|
|
Interest
expense
|
-
|
(90
)
|
(74
)
|
-
|
(164
)
|
|
Other
expense (income)
|
-
|
5
|
2
|
-
|
7
|
|
Total
other (income) expense
|
-
|
(85
)
|
(72
)
|
-
|
(157
)
|
|
Income
(loss) from discontinued operations
|
(3
)
|
(57
)
|
39
|
4
|
(14
)
|
|
Income
tax provision from discontinued operations
|
-
|
-
|
-
|
-
|
-
|
|
Net
income (loss) from discontinued operations
|
$
(3
)
|
$
(57
)
|
$
39
|
$
4
|
$
(14
)
|
|
|
Three
Months ended March 31,
|
|
|
|
2021
|
2020
|
|
Cash
paid for interest - continuing operations
|
$
-
|
$
506
|
|
Cash
paid for taxes - continuing operations
|
-
|
-
|
|
Non-cash
investing and financing activities
|
|
|
|
Paid-in-kind
interest transferred from accrued interest to the principal balance
of the 2019 Promissory Notes
|
-
|
1,283
|
|
Financing
activities:
|
|
|
|
Series
A Cumulative Convertible Redeemable Preferred stock dividends
included in accounts payable and accrued expenses, settled in
common stock
|
(1,005
)
|
-
|
|
Series
A Cumulative Convertible Redeemable Preferred stock included in
temporary equity, settled in common stock
|
(6,770
)
|
-
|
|
Series
B Cumulative Convertible Preferred stock dividends included in
accounts payable and accrued expenses, settled in common
stock
|
(179
)
|
-
|
|
Adoption
of ASC-842 Lease Accounting:
|
|
|
|
Right-of-use
lease asset
|
-
|
132
|
|
Lease
liability
|
$
-
|
$
(132
)
|
|
Operating
lease right-of-use lease assets from continuing
operations
|
$
352
|
|
|
|
|
Current
portion of lease liability
|
$
199
|
|
Long-term
portion of lease liability
|
167
|
|
Total
lease liability from continuing operations
|
$
366
|
|
|
|
|
Weighted
average remaining lease term - operating leases from continuing
operations
|
2.11
|
|
|
|
|
Weighted
average discount rate - operating leases
|
9
%
|
|
|
|
|
2021
|
$
193
|
|
2022
|
104
|
|
2023
|
84
|
|
2024
|
19
|
|
Total
lease payments
|
$
400
|
|
Less
imputed interest
|
34
|
|
Maturities
of lease liabilities
|
$
366
|
|
|
December 31,
2020
|
Additions
|
Amortization
|
March 31,
2021
|
|
Intangible
assets subject to amortization from continuing
operations
|
|
|
|
|
|
Customer
relationships
|
$
362
|
$
-
|
$
(8
)
|
$
354
|
|
Marketing
related
|
159
|
-
|
(18
)
|
141
|
|
Technology
based
|
5,361
|
4
|
(262
)
|
5,103
|
|
Internally
capitalized software
|
1,156
|
-
|
(121
)
|
1,035
|
|
Intangible
assets subject to amortization from continuing
operations
|
$
7,038
|
$
4
|
$
(409
)
|
$
6,633
|
|
|
Customer Relationships
|
Marketing Related
|
Technology Based
|
Internally Capitalized Software
|
Total
|
|
Identifiable
intangible assets
|
$
461
|
$
327
|
$
7,210
|
$
1,452
|
$
9,450
|
|
Accumulated
amortization
|
(107
)
|
(186
)
|
(2,107
)
|
(417
)
|
(2,817
)
|
|
Identifiable
intangible assets from continuing operations, net
|
$
354
|
$
141
|
$
5,103
|
$
1,035
|
$
6,633
|
|
2021
|
$
1,216
|
|
2022
|
1,543
|
|
2023
|
1,363
|
|
2024
|
1,060
|
|
2025
|
1,051
|
|
Thereafter
|
400
|
|
Total
|
$
6,633
|
|
|
Three
Months ended March 31,
|
|
|
|
2021
|
2020
|
|
Contractual
interest
|
$
27
|
$
833
|
|
Amortization
of debt issuance costs
|
5
|
330
|
|
Total
interest expense
|
$
32
|
$
1,163
|
|
2021
|
$
506
|
|
2022
|
1,432
|
|
2023
|
37
|
|
Total
|
1,975
|
|
|
|
|
Less
unamortized interest
|
(15
)
|
|
Total
notes payable
|
$
1,960
|
|
|
|
|
Loan
payable, current portion
|
$
625
|
|
Loan
payable, long-term
|
350
|
|
Notes
payable, current portion
|
985
|
|
Total
notes payable
|
$
1,960
|
|
|
Series A Preferred Stock Warrants (1)
|
Firestorm Warrants (2)
|
Secure Education Warrants (3)
|
2018 Public Offering Warrants (4)
|
2019 Promissory Note Warrants (5)
|
Total
|
|
Active
warrants January 1, 2021
|
141,789
|
631,254
|
66,666
|
4,886
|
68,750
|
913,345
|
|
Exercised
warrants
|
(95,864
)
|
-
|
(48,888
)
|
(1,175
)
|
(53,125
)
|
(199,052
)
|
|
Outstanding
warrants March 31, 2021
|
45,925
|
631,254
|
17,778
|
3,711
|
15,625
|
714,293
|
|
Weighted
average strike price of outstanding warrants
|
$
1.03
|
$
3.09
|
$
5.86
|
$
1.00
|
$
0.74
|
$
2.96
|
|
Shares
of common stock issued during the three months ended March 31,
2021
|
95,864
|
-
|
48,888
|
1,083
|
49,654
|
195,489
|
|
|
Number of Shares
Subject to Option
|
Weighted Average
Exercise Price
|
Weighted Average
Remaining Contractual Term (Years)
|
Aggregate Intrinsic
Value
|
|
Outstanding
Balance at December 31, 2020
|
1,243,254
|
$
1.44
|
7.57
|
$
7,827
|
|
Exercised
|
(65,402
)
|
3.47
|
-
|
|
|
Forfeited
|
(10,000
)
|
0.80
|
-
|
|
|
Outstanding
Balance at March 31, 2021
|
1,167,852
|
$
1.33
|
7.34
|
$
20,701
|
|
Exercisable
at March 31, 2021
|
810,339
|
$
1.44
|
6.99
|
$
14,658
|
|
|
Number of
Shares
|
Weighted Average
Unit Price
|
Weighted Average
Remaining Contractual Term (Years)
|
|
Outstanding
Balance at December 31, 2020
|
479,984
|
$
4.45
|
2.12
|
|
Granted
|
285,040
|
14.10
|
1.71
|
|
Vested
|
(155,869)
(1)
|
5.69
|
-
|
|
Forfeited
|
(54,550
)
|
2.90
|
-
|
|
Outstanding
Balance at March 31, 2021
|
554,605
|
$
9.21
|
2.01
|
|
|
Three Months ended
March 31,
|
|
|
|
2021
|
2020
|
|
|
(Dollars in
thousands, except per share data)
|
|
|
Basic and diluted
loss per share
|
|
|
|
Net
loss from continuing operations
|
$
(5,403
)
|
$
(3,774
)
|
|
Less:
preferred stock accretion
|
(101
)
|
(206
)
|
|
Less:
preferred stock dividends
|
(51
)
|
(115
)
|
|
Net
loss attributable to shareholders from continuing
operations
|
$
(5,555
)
|
$
(4,095
)
|
|
Net loss from
discontinued operations
|
(3
)
|
(14
)
|
|
Net loss
attributable to shareholders
|
$
(5,558
)
|
$
(4,109
)
|
|
Weighted
average common shares outstanding - basic and diluted
|
35,944,355
|
21,929,768
|
|
Basic
and diluted loss per share from continuing operations
|
(0.15
)
|
(0.19
)
|
|
Basic
and diluted loss per share from discontinued
operations
|
-
|
-
|
|
Basic and diluted
loss per share
|
$
(0.15
)
|
$
(0.19
)
|
|
Common
stock equivalents excluded due to anti-dilutive effect
|
2,436,750
|
5,293,838
|
|
|
Three
months ended March 31,
|
|
|
(dollars in
thousands)
|
2021
|
2020
|
|
Revenue
|
$
4,216
|
$
1,595
|
|
Cost
of revenue
|
1,962
|
494
|
|
Gross
profit
|
2,254
|
1,101
|
|
|
|
|
|
Operating
expenses:
|
|
|
|
General
and administrative expenses
|
5,403
|
2,791
|
|
Selling
and marketing expenses
|
937
|
371
|
|
Research
and development expenses
|
1,222
|
543
|
|
Operating
expenses
|
7,562
|
3,705
|
|
|
|
|
|
Loss
from operations
|
(5,308
)
|
(2,604
)
|
|
Other
income (expense):
|
|
|
|
Interest
expense
|
(32
)
|
(1,163
)
|
|
Other
income
|
16
|
-
|
|
Total
other expense
|
(16
)
|
(1,163
)
|
|
Loss
before income taxes
|
(5,324
)
|
(3,767
)
|
|
Income
tax provision
|
(3
)
|
(7
)
|
|
Equity
in loss of investee
|
(76
)
|
-
|
|
Net
loss from continuing operations
|
(5,403
)
|
(3,774
)
|
|
Net
loss from discontinued operations
|
(3
)
|
(14
)
|
|
Net
loss
|
$
(5,406
)
|
$
(3,788
)
|
|
Comprehensive
loss:
|
|
|
|
Net
loss from continuing operations
|
(5,403
)
|
(3,774
)
|
|
Change
in unrealized gain on short-term investments
|
2
|
-
|
|
Total
comprehensive loss from continuing operations
|
(5,401
)
|
(3,774
)
|
|
Total
comprehensive loss
|
$
(5,404
)
|
$
(3,788
)
|
|
|
Three
Months ended March 31,
|
Change
|
||
|
(dollars
in thousands)
|
2021
|
2020
|
$
|
%
|
|
Revenue
|
$
4,216
|
$
1,595
|
$
2,621
|
164
%
|
|
|
Three Months ended March 31,
|
Change
|
||
|
(dollars
in thousands)
|
2021
|
2020
|
$ or % Points
|
%
|
|
Cost
of revenue
|
$
1,962
|
$
494
|
$
1,468
|
297
%
|
|
Gross
profit
|
2,254
|
1,101
|
1,153
|
105
%
|
|
Gross
margin
|
53
%
|
69
%
|
-16
%
|
-23
%
|
|
|
Three Months ended March 31,
|
Change
|
||
|
(dollars
in thousands)
|
2021
|
2020
|
$
|
%
|
|
Operating
expenses:
|
|
|
|
|
|
General
and administrative expenses
|
$
5,403
|
$
2,791
|
$
2,612
|
94
%
|
|
Selling
and marketing expenses
|
937
|
371
|
566
|
153
%
|
|
Research
and development expenses
|
1,222
|
543
|
679
|
125
%
|
|
Operating
expenses
|
$
7,562
|
$
3,705
|
$
3,857
|
104
%
|
|
|
Three Months ended March 31,
|
Change
|
||
|
(dollars
in thousands)
|
2021
|
2020
|
$
|
%
|
|
Other
income (expense):
|
|
|
|
|
|
Interest
expense
|
$
(32
)
|
$
(1,163
)
|
$
1,131
|
97
%
|
|
Other
income
|
16
|
-
|
16
|
100
%
|
|
Total
other expense
|
$
(16
)
|
$
(1,163
)
|
$
1,147
|
99
%
|
|
|
Three
Months ended March 31,
|
|
|
|
2021
|
2020
|
|
Total
comprehensive loss from continuing operations
|
$
(5,401
)
|
$
(3,774
)
|
|
Income
taxes
|
3
|
7
|
|
Interest
|
32
|
1,163
|
|
Depreciation
and amortization
|
614
|
423
|
|
EBITDA
|
$
(4,752
)
|
$
(2,181
)
|
|
|
|
|
|
Share-based
compensation
|
781
|
171
|
|
Loss
due to change in value of equity investments
|
76
|
-
|
|
One-time
consulting fees
|
776
|
-
|
|
Adjusted
EBITDA
|
$
(3,119
)
|
$
(2,010
)
|
|
|
Three
Months ended March 31,
|
|||
|
|
2021
|
2020
|
Change
|
|
|
|
|
$
|
%
|
|
|
Net
cash used in operating activities - continuing
operations
|
$
(3,159
)
|
$
(2,444
)
|
$
(715
)
|
-29
%
|
|
Net
cash used in investing activities - continuing
operations
|
(24,420
)
|
(178
)
|
(24,242
)
|
-13,619
%
|
|
Net
cash provided by financing activities - continuing
operations
|
70,425
|
2,523
|
67,902
|
2,691
%
|
|
Net
increase (decrease) in cash, cash equivalents and restricted cash
and cash equivalents - continuing operations
|
$
42,846
|
$
(99
)
|
$
42,945
|
43,379
%
|
|
|
|
|
|
Incorporated by Reference
|
|
|
||||||
|
Exhibit Number
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
Filed/
Furnished
Herewith
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amended
and Restated Certificate of Incorporation of Novume Solutions, Inc.
as filed with the Secretary of State of Delaware on August 21,
2017
|
|
8-K
|
|
333-216014
|
|
3.1
|
|
8/25/17
|
|
|
|
|
|
Certificate
of Designations of Series A Cumulative Convertible Redeemable
Preferred Stock as filed with the Secretary of State of Delaware on
August 25, 2017
|
|
8-K
|
|
333-216014
|
|
4.1
|
|
8/25/17
|
|
|
|
|
|
Certificate
of Designations of Novume Series B Cumulative Convertible Preferred
Stock as filed with the Secretary of State of Delaware on August
21, 2017
|
|
8-K
|
|
000-55833
|
|
4.2
|
|
10/4/17
|
|
|
|
|
|
Certificate
of Amendment to Amended and Restated Certificate of Incorporation
of Novume Solutions, Inc. as filed with the Secretary of State of
Delaware on April 26, 2019
|
|
8-K
|
|
001-38338
|
|
3.1
|
|
4/30/19
|
|
|
|
|
|
Second
Certificate of Amendment to Amended and Restated Certificate of
Incorporation of Rekor Systems, Inc. as filed with the Secretary of
State of Delaware on March 18, 2020
|
|
8-K
|
|
001-38338
|
|
3.1
|
|
3/18/20
|
|
|
|
|
|
Amended
and Restated Bylaws of Rekor Systems, Inc.
|
|
8-K
|
|
001-38338
|
|
3.2
|
|
4/30/19
|
|
|
|
|
10.1
|
|
Agreement
of Lease by and between 6721 Gateway, LLC and Rekor Systems, Inc.
dated March 25, 2021.
|
|
|
|
|
|
|
|
|
|
*
|
|
|
Rule
13a-14(a)/15d-14(a) Certification of Chief Executive
Officer
|
|
|
|
|
|
|
|
|
|
*
|
|
|
|
Rule
13a-14(a)/15d-14(a) Certification of Chief Financial
Officer
|
|
|
|
|
|
|
|
|
|
*
|
|
|
|
Section
1350 Certification of Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
**
|
|
|
|
Section
1350 Certification of Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
**
|
|
|
101.INS
|
|
XBRL
Instance Document
|
|
|
|
|
|
|
|
|
|
*
|
|
101.SCH
|
|
XBRL
Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
*
|
|
101.CAL
|
|
XBRL
Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
*
|
|
101.LAB
|
|
XBRL
Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
*
|
|
101.PRE
|
|
XBRL
Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
*
|
|
101.DEF
|
|
XBRL
Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
*
|
|
|
Rekor Systems,
Inc.
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Robert A. Berman
|
|
|
|
Name:
|
Robert
A. Berman
|
|
|
|
Title:
|
President
and Chief Executive Officer
Principal
Executive Officer
|
|
|
|
Date:
|
May 10,
2021
|
|
|
|
|
|
|
|
|
By:
|
/s/
Eyal Hen
|
|
|
|
Name:
|
Eyal
Hen
|
|
|
|
Title:
|
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
|
|
|
Date:
|
May 10,
2021
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|